telesisbio.com - TBIO Earnings growth forecast for next year
The closed consumables ecosystem for BioXp stabilizes costs for Telesis Bio, Inc. (TBIO), which confirms the adjustment of earnings per share target estimates. The 0.00 mark indicates the current consensus level. Leadership in mRNA synthesis driven by R&D investments faces geopolitical restrictions on the export of dual-use technologies, which hinders expansion into isolated markets.
telesisbio.com - analytical breakdowns and key metrics (TBIO)
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt and solvency information:
Total Debt to Equity Ratio Telesis Bio, Inc.|TBIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Telesis Bio|TBIO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Telesis Bio|TBIO - Company Long-Term Indebtedness|Company Short-Term Debts Telesis Bio|Quick Liquidity Indicator telesisbio.com
- earnings and valuation multiples information:
TBIO - Net Financial Result|Future Profit Telesis Bio, Inc.|TBIO - Market Price to Net Income Ratio|Forward P/E Multiple Telesis Bio, Inc.|TBIO - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Telesis Bio|TBIO - Operating income before deduction of amortization|Earnings per share for the last twelve months Telesis Bio|TBIO - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth telesisbio.com|TBIO - Earnings per share growth this year|Net earnings per share growth forecast for next year Telesis Bio, Inc.
- revenue and sales details:
Initial company analysis:TBIO, Codex DNA
Telesis Bio, Inc. (TBIO) remains insulated from macroeconomic shocks, and stable demand for medtech innovations positions the company as a defensive asset whose value depends on the efficiency of cost management. Analyzing the projected earnings per share (EPS) dynamics helps smooth out quarterly volatility, revealing the real profitability trend and the impact of inflation on margins, which is critical for fundamental stock selection.
Competing companies
Expected earnings per share growth for next year TEM|QGEN: Expected earnings per share trend next year|Earnings growth forecast for next year IONS|Net earnings per share growth forecast for next year RGEN (repligen.com)|Earnings growth forecast for next year RNA (Avidity Biosciences, Inc.)|Consensus forecast of earnings per share growth for next year CRISPR Therapeutics Inc (CRSP)|WGS - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Ultragenyx Corp|BEAM (Beam Therapeutics Inc.) - Expected earnings per share growth for next year|sarepta.com - Expected earnings per share trend next year|TWST (Twist Bioscience, Inc.) - Earnings growth forecast for next year|10x Genomics Inc (TXG) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Intellia (NTLA)|Stoke Corp - Projected earnings per share growth rate for next year|Earnings growth forecast for next year BLFS (BioLife Solutions, Inc.)|WVE - Expected earnings per share growth for next year|MAZE: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Sionna Therapeutics, Inc. SION|PRME (Prime Medicine Corp) - Expected earnings per share growth for next year|TSHA: Projected earnings per share increase next year|QURE (uniQure N.V.) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MGTX|Earnings growth forecast for next year RGNX|Consensus forecast of earnings per share growth for next year Solid Biosciences Inc|Net earnings per share growth forecast for next year Ocugen Corp OCGN|PacBio Corp (PACB) - Expected net earnings per share growth next year|Benitec Biopharma Inc. - Earnings growth forecast for next year|DSGN (designtx.com) - Projected earnings per share growth rate for next year|Rocket Pharmaceuticals, Inc. (RCKT) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year FDMT|LXEO (Lexeo Therapeutics Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Korro Bio, Inc|Expected earnings per share growth for next year EDIT (Editas Medicine, Inc.)|Projected earnings per share increase next year SLN|Earnings growth forecast for next year PRQR (ProQR Therapeutics)|Codexis Inc (CDXS) - Expected net earnings per share growth next year|SGMO - Net earnings per share growth forecast for next year|NAUT: Net earnings per share growth forecast for next year|MGX: Earnings growth forecast for next year|Expected net earnings per share growth next year Precision BioSciences Inc. (DTIL)|Net earnings per share growth forecast for next year Generation Bio Co|Boundless Bio Inc. (BOLD) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year XCUR|Consensus forecast of earnings per share growth for next year imunon.com|Net earnings per share growth forecast for next year Phio Pharmaceuticals Corp. PHIO|Consensus forecast of earnings per share growth for next year Mustang Bio Inc (MBIO)|RNAZ: Expected earnings per share growth for next year|Expected earnings per share trend next year BNGO (Bionano Genomics, Inc.)|APDN: Earnings growth forecast for next year|BLUE (bluebird bio, Inc) - Net earnings per share growth forecast for next year|IPA (ImmunoPrecise Antibodies Ltd) - Earnings growth forecast for next year|omegatherapeutics.com (OMGA) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Singular Genomics (OMIC)|RGLS - Expected net earnings per share growth next year|Syros - Expected earnings per share growth for next year|Expected earnings per share trend next year TCON|Unity Biotechnology - Earnings growth forecast for next year
